This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Imaging Biometrics, a wholly owned subsidiary of IQ-AI, is highlighting results from a recent glioma study published in Neuroradiology. The study, led by Siem Herings, from Radboud University Medical Center in Nijmegen, the Netherlands -- Herings is a member of the lab of Dylan Henssen, MD, PhD -- validates the benefit of the company's IB Rad Tech workflow software for distinguishing treatment effect from tumor progression in post-treatment glioma patients.
Targeted Alpha Radionuclide Therapy precisely delivers potent alpha particles to tumors, maximising efficacy while sparing healthy tissues. The post The Role of Targeted Alpha Radionuclide Therapy in Modern Oncology appeared first on Open MedScience.
Ascelia Pharma is highlighting results from a phase III study for its liver imaging drug candidate, Orviglance. The study showed superior performance for visualizing focal liver lesions with Orviglance compared with unenhanced MRI, with statistical significance for all study three readers ( Ascelia Pharma is developing the drug as a contrast agent for use in liver MRI in patients with severely impaired kidney function; Orviglance has been granted orphan drug designation from the U.S.
Depression, a pervasive mental health disorder, affects millions worldwide. Among various treatment options, paroxetine hydrochloride stands out. Known for its efficacy in addressing depressive symptoms, it remains a subject of continuous study. This article delves into the characteristics of Fenamon SR , a sustained-release form, and its place in therapeutic regimes.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Particular CT imaging findings can help clinicians diagnose negative effects of the use of adulterated cannabinoids, according to research presented at the American Roentgen Ray Society (ARRS) annual meeting. A team led by Nitai Bar, MD, of Rambam Healthcare Campus in Haifa, Israel, reported that suburothelial hemorrhage and intramural bowel hematomas found on CT imaging were indicative of coagulopathy linked to contaminated cannabinoids such as THC (tetrahydrocannabinol), CBD (cannabidiol), CBG
This study aims to characterize the relationship between ablation zone volume (AZV) and microwave ablation (MWA) energy in an in vivo porcine liver model following arterial embolization.
This study aims to characterize the relationship between ablation zone volume (AZV) and microwave ablation (MWA) energy in an in vivo porcine liver model following arterial embolization.
Reinforced cementoplasty with spindles is a recent technique that is mainly used for pathological fractures or for bone metastases at risk of fracture in locations with shear stresses. The technique is less challenging to perform than percutaneous screw insertion and does not require equipment sterilization. No general anesthetic is required. A small trocar is all that is needed, and sutures are often unnecessary.
40
40
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content